Skip to main content
Top
Published in: BMC Pediatrics 1/2018

Open Access 01-12-2018 | Case report

Atypical CHARGE associated with a novel frameshift mutation of CHD7 in a Chinese neonatal patient

Authors: Yan-ping Xu, Li-ping Shi, Jiajun Zhu

Published in: BMC Pediatrics | Issue 1/2018

Login to get access

Abstract

Background

CHARGE syndrome is an autosomal dominant malformation disorder caused by heterozygous loss of function mutations in the chromatin remodeler CHD7, which has been estimated to occur in 1:10,000 births worldwide. It is a genetic disorder closely resembles other pattern of anomalies. Genetic testing should be pointed out as a useful method for clinical diagnosis.

Case presentation

A female infant was the second child born to a 33-year-old, gravida 3, para 2 mother. The infant was born at 37 + 4 weeks of gestation with a birth weight of 2440 g (− 1.1 S.D.). Clinical examination showed atypical CHARGE syndrome, with choanal atresia, a heart defect, and sensorineural deafness. Genomic DNA was extracted from peripheral venous blood sample using molecular biological technique. We used the Illumina TruSigt One sequencing panel on the MiSeq next- generation sequencing (NGS) platform for mutation screening and found a novel frameshift mutation in chromodomain helicase DNA binding protein 7 (CHD7; c.4656dupT). This mutation results in a new reading frame ending in p.(Ile1553fs). At the first month of age, the patient had a posterior nostril plasty operation by nasal endoscope. At the second month of age, she had patent ductus arteriosus ligation surgery. At the 4th month of age, she was discharged from the hospital.

Conclusions

Our findings further reveal that patients should not be rejected for CHD7 mutational analysis even if they do not fulfill CHARGE syndrome Verloes criteria.
Literature
1.
go back to reference Jongmans MC, Admiraal RJ, van der Donk KP, et al. CHARGE syndrome: the phenotypic spectrum of mutations in the CHD7 gene. J Med Genet. 2006;43(4):306–14.CrossRefPubMed Jongmans MC, Admiraal RJ, van der Donk KP, et al. CHARGE syndrome: the phenotypic spectrum of mutations in the CHD7 gene. J Med Genet. 2006;43(4):306–14.CrossRefPubMed
2.
go back to reference Hittner HM, Hirsch NJ, Kreh GM, Rudolph AJ. Colobomatous microphthalmia, heart disease, hearing loss, and mental retardation--a syndrome. J Pediatr Ophthalmol Strabismus. 1979;16(2):122–8.PubMed Hittner HM, Hirsch NJ, Kreh GM, Rudolph AJ. Colobomatous microphthalmia, heart disease, hearing loss, and mental retardation--a syndrome. J Pediatr Ophthalmol Strabismus. 1979;16(2):122–8.PubMed
3.
4.
go back to reference Zentner GE, Layman WS, Martin DM, Scacheri PC. Molecular and phenotypic aspects of CHD7 mutation in CHARGE syndrome. Am J Med Genet A. 2010;152A(3):674–86.CrossRefPubMedPubMedCentral Zentner GE, Layman WS, Martin DM, Scacheri PC. Molecular and phenotypic aspects of CHD7 mutation in CHARGE syndrome. Am J Med Genet A. 2010;152A(3):674–86.CrossRefPubMedPubMedCentral
5.
go back to reference Lehalle D, Gordon CT, Oufadem M, et al. Delineation of EFTUD2 haploinsufficiency-related phenotypes through a series of 36 patients. Hum Mutat. 2014;35(4):478–85.CrossRefPubMed Lehalle D, Gordon CT, Oufadem M, et al. Delineation of EFTUD2 haploinsufficiency-related phenotypes through a series of 36 patients. Hum Mutat. 2014;35(4):478–85.CrossRefPubMed
6.
go back to reference Luquetti DV, Hing AV, Rieder MJ, et al. "Mandibulofacial dysostosis with microcephaly" caused by EFTUD2 mutations: expanding the phenotype. Am J Med Genet A. 2013;161A(1):108–13.CrossRefPubMed Luquetti DV, Hing AV, Rieder MJ, et al. "Mandibulofacial dysostosis with microcephaly" caused by EFTUD2 mutations: expanding the phenotype. Am J Med Genet A. 2013;161A(1):108–13.CrossRefPubMed
7.
go back to reference Mamanova L, Coffey AJ, Scott CE, et al. Target-enrichment strategies for next-generation sequencing. Nat Methods. 2010;7(2):111–8.CrossRefPubMed Mamanova L, Coffey AJ, Scott CE, et al. Target-enrichment strategies for next-generation sequencing. Nat Methods. 2010;7(2):111–8.CrossRefPubMed
8.
9.
go back to reference Palumbo O, Palumbo P, Stallone R, Palladino T, Zelante L, Carella M. 8q12.1q12.3 de novo microdeletion involving the CHD7 gene in a patient without the major features of CHARGE syndrome: case report and critical review of the literature. Gene. 2013;513(1):209–13.CrossRefPubMed Palumbo O, Palumbo P, Stallone R, Palladino T, Zelante L, Carella M. 8q12.1q12.3 de novo microdeletion involving the CHD7 gene in a patient without the major features of CHARGE syndrome: case report and critical review of the literature. Gene. 2013;513(1):209–13.CrossRefPubMed
10.
go back to reference Shoji Y, Ida S, Etani Y, et al. Endocrinological characteristics of 25 Japanese patients with CHARGE syndrome. Clin Pediatr Endocrinol. 2014;23(2):45–51.CrossRefPubMedPubMedCentral Shoji Y, Ida S, Etani Y, et al. Endocrinological characteristics of 25 Japanese patients with CHARGE syndrome. Clin Pediatr Endocrinol. 2014;23(2):45–51.CrossRefPubMedPubMedCentral
11.
go back to reference Lee B, Duz MB, Sagong B, et al. Revealing the function of a novel splice-site mutation of CHD7 in CHARGE syndrome. Gene. 2016;576(2 Pt 2):776–81.CrossRefPubMed Lee B, Duz MB, Sagong B, et al. Revealing the function of a novel splice-site mutation of CHD7 in CHARGE syndrome. Gene. 2016;576(2 Pt 2):776–81.CrossRefPubMed
12.
go back to reference Vatta M, Niu Z, Lupski JR, et al. Evidence for replicative mechanism in a CHD7 rearrangement in a patient with CHARGE syndrome. Am J Med Genet A. 2013;161A(12):3182–6.CrossRefPubMed Vatta M, Niu Z, Lupski JR, et al. Evidence for replicative mechanism in a CHD7 rearrangement in a patient with CHARGE syndrome. Am J Med Genet A. 2013;161A(12):3182–6.CrossRefPubMed
13.
go back to reference Verloes A. Updated diagnostic criteria for CHARGE syndrome: a proposal. Am J Med Genet A. 2005;133A(3):306–8.CrossRefPubMed Verloes A. Updated diagnostic criteria for CHARGE syndrome: a proposal. Am J Med Genet A. 2005;133A(3):306–8.CrossRefPubMed
14.
go back to reference Chai M, Sanosaka T, Okuno H, et al. Chromatin remodeler CHD7 regulates the stem cell identity of human neural progenitors. Genes Dev. 2018;32(2):165–80.CrossRefPubMedPubMedCentral Chai M, Sanosaka T, Okuno H, et al. Chromatin remodeler CHD7 regulates the stem cell identity of human neural progenitors. Genes Dev. 2018;32(2):165–80.CrossRefPubMedPubMedCentral
15.
go back to reference Okuno H, Renault MF, Ohta S, et al. CHARGE syndrome modeling using patient-iPSCs reveals defective migration of neural crest cells harboring CHD7 mutations. Elife. 2017;28:6. Okuno H, Renault MF, Ohta S, et al. CHARGE syndrome modeling using patient-iPSCs reveals defective migration of neural crest cells harboring CHD7 mutations. Elife. 2017;28:6.
16.
go back to reference Hefner MA, Fassi E. Genetic counseling in CHARGE syndrome: diagnostic evaluation through follow up. Am J Med Genet C Semin Med Genet. 2017;175(4):407–16.CrossRefPubMed Hefner MA, Fassi E. Genetic counseling in CHARGE syndrome: diagnostic evaluation through follow up. Am J Med Genet C Semin Med Genet. 2017;175(4):407–16.CrossRefPubMed
Metadata
Title
Atypical CHARGE associated with a novel frameshift mutation of CHD7 in a Chinese neonatal patient
Authors
Yan-ping Xu
Li-ping Shi
Jiajun Zhu
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Pediatrics / Issue 1/2018
Electronic ISSN: 1471-2431
DOI
https://doi.org/10.1186/s12887-018-1181-0

Other articles of this Issue 1/2018

BMC Pediatrics 1/2018 Go to the issue